Press "Enter" to skip to content

Cipla gets EIR from USFDA for Kurkumbh facility

The Kurkumbh manufacturing facility was inspected by the United States Food and Drug Administration (USFDA) from March 11 to March 20, 2019, Cipla said in a BSE filing.

Original source: https://health.economictimes.indiatimes.com/news/pharma/cipla-gets-eir-from-usfda-for-kurkumbh-facility/69726700?utm_source=RSS&utm_medium=ETRSS

Also Read:   Diets with more fiber, yogurt tied to lower risk of lung cancer